Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-10 Sale |
2024-12-11 5:17 pm |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $9.4622 | $283,866 | 747,663 (Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 7:39 pm |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $9.27 | $278,100 | 777,663 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-08 Equity Swap |
2025-01-10 4:10 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd 10% Owner |
11,835,673 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:17 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
58,950 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:17 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
58,950 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:16 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
58,950 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:15 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
68,950 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:14 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director |
58,950 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:12 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director |
78,600 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:11 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
254,852 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:10 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer |
185,000 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:09 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
223,640 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:08 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO |
636,726 | $0 | 0 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:07 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO |
615,836 | $0 | 0 (Direct) |
View |
| 2025-01-02 Tax Withholding |
2025-01-03 8:24 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
23,313 | $9.6 | 630,726 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-11 5:17 pm |
N/A 2028-03-01 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $0 | 747,663 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-11 5:17 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $2.781 | 747,663 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-27 7:39 pm |
N/A 2028-03-01 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $0 | 777,663 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-27 7:39 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
30,000 | $2.781 | 777,663 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:16 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:16 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
47,000 | $0 | 96,300 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:15 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:14 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:13 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director |
47,000 | $0 | 105,950 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:12 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 4:03 pm |
N/A 2034-03-31 |
Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer |
435,000 | $0 | 435,000 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-04 5:29 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
18,091 | $4.13 | 357,983 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:29 pm |
N/A 2034-02-28 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer |
192,443 | $0 | 357,983 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-04 5:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
34,157 | $4.13 | 651,291 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-04 5:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
16,306 | $4.13 | 326,340 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:18 pm |
N/A 2034-02-28 |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
192,443 | $0 | 326,340 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-04 5:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy |
35,739 | $4.13 | 530,740 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 5:18 pm |
N/A 2034-02-28 |
Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy |
192,443 | $0 | 530,740 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-02 8:51 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
47,162 | $3.41 | 685,448 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:03 pm |
N/A 2034-01-01 |
Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO |
595,200 | $0 | 952,036 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:02 pm |
N/A 2034-01-01 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman |
297,600 | $0 | 905,210 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:10 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director |
47,000 | $0 | 66,650 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:09 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
47,000 | $0 | 66,650 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:09 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
47,000 | $0 | 76,650 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:08 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:07 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
47,000 | $0 | 66,650 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 4:14 pm |
N/A 2033-04-30 |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
94,500 | $0 | 94,500 (Direct) |
View |
| 2023-04-11 Option Award |
2023-04-12 4:49 pm |
N/A 2033-04-10 |
Poseida Therapeutics Inc. | PSTX | Yarema Kristin President, Cell Therapy |
855,161 | $0 | 855,161 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-02 6:30 pm |
N/A 2033-02-28 |
Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy |
218,055 | $0 | 499,319 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-02 6:30 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy |
26,617 | $5.35 | 499,319 (Direct) |
View |